News Release

INDIANAPOLIS — Attorney General Todd Rokita announced Monday, July 28, a major national opioid settlement — his 11th since taking office — that secures approximately $720 million from eight pharmaceutical manufacturers accused of fueling the nation’s opioid crisis. Indiana is expected to receive approximately $16.5 million from the settlement.

Todd Rokita

The settlement holds Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun and Zydus accountable for their roles in manufacturing and distributing addictive opioid medications that contributed to widespread addiction and loss of life across the country.

“Thousands of Hoosiers have lost their lives as a result of the opioid crisis,” said Rokita. “We can never undo that tragic loss of life, but we can hold accountable those responsible for contributing to the situations culminating in these deaths. That’s what these settlements are all about, and I’m proud of the work of our team.”

Settlement Terms

The settlement imposes strict injunctive relief requirements on all eight companies, including:

A ban on promoting opioids or opioid products.

A prohibition on financial incentives or disciplinary actions based on opioid sales volume.

A restriction against manufacturing, promoting, or distributing high-dosage opioid products (more than 40mg of oxycodone per pill).

A ban on discounts, coupons, or rebates for opioid medications.

A ban on funding third-party opioid promotion or engaging in any opioid-related lobbying activities.

In addition, seven of the eight companies will be required to comply with suspicious order monitoring protocols similar to those in previous national opioid settlements. Indivior, which primarily manufactures opioid use disorder treatments, has agreed not to manufacture or sell any opioid products for the next 10 years.

The payment structures vary by company: some will make annual payments over time, while others will fulfill their financial obligations with a lump-sum payment.

With this latest agreement, Indiana has now secured approximately $1.1 billion in total opioid settlement funds since Rokita assumed office in January 2021. These funds will continue to support prevention, education, treatment, and recovery efforts across Indiana communities hardest hit by the opioid epidemic.